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Examination of predictors of late-life cognitive functioning is particularly salient in
at-risk older adults, such as those who have been recently hospitalized. Sleep and
inflammation are independently related to late-life cognitive functioning. The potential role
of sleep as a moderator of the relationship between inflammation and global cognitive
functioning has not been adequately addressed. We examined the relationship between
self-reported sleep duration, inflammatory markers, and general cognitive functioning
in hospitalized older men. Older men (n = 135; Mean age = 72.9 ± 9.7 years) were
recruited from inpatient rehabilitation units at a VA Medical Center to participate in a
cross-sectional study of sleep. Participants completed theMini-Mental State Examination
and Pittsburgh Sleep Quality Index, and underwent an 8 a.m. blood draw to measure
inflammatory markers [i.e., C-reactive protein (CRP), tumor necrosis factor alpha (TNFα),
soluble intercellular adhesion molecule-1 (sICAM-1), and interleukin-6 (IL-6)]. Hierarchical
regression analyses (controlling for age, education, race, depression, pain, health
comorbidity, and BMI) revealed that higher levels of CRP and sICAM are associated with
higher global cognitive functioning in older men with sleep duration ≥6 h (β = −0.19,
β = −0.18, p’s < 0.05, respectively), but not in those with short sleep durations
(p’s > 0.05). In elderly hospitalized men, sleep duration moderates the association
between inflammation and cognitive functioning. These findings have implications for
the clinical care of older men within medical settings.
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Introduction
Cross-sectional and longitudinal studies demonstrate a decline in cognitive functioning with
advanced age. Identification of predictors of cognitive functioning in older adults is a key step
in efforts to prolong late-life vitality. Both sleep (Blackwell et al., 2006; McCrae et al., 2012) and
inflammation (Weaver et al., 2002; Teunissen et al., 2003; Baune et al., 2008) have demonstrated
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inconsistent associations with late-life cognitive functioning. We
sought to clarify the relationships among sleep, inflammation,
and cognitive functioning in older adults for whom impairments
in cognitive functioning are particularly salient, in this case
hospitalized patients (Wilson et al., 2012).
Advanced age is associated with changes in sleep duration,
quantity, and architecture (Morgan, 2000). These age-related
changes in sleep appear to be magnified in inpatient settings,
where older adults commonly suffer from extremely fragmented
sleep and have short nighttime sleep duration (Drouot et al.,
2008; Isaia et al., 2011). While disturbed sleep in these settings
predicts increased mortality risk within 1 year (Martin et al.,
2011), the relationship between sleep and cognitive functioning
in the inpatient setting is unknown.
In community-dwelling older adults, habitual self-reported
sleep duration has shown some promise as a predictor of
global cognitive functioning. However, inconsistent results limit
the conclusions that can be drawn regarding the relationship
between sleep duration and cognitive functioning. For example,
no association between sleep duration and executive functioning
has been reported (Nebes et al., 2009), whereas, others have
reported that older adults with short sleep durations have
lower levels of global cognitive functioning (Tworoger et al.,
2006; Kronholm et al., 2009). Still other researchers observed
relationships between long sleep duration, but not short sleep
duration, and general cognitive functioning (Faubel et al., 2009).
Beyond our recent work demonstrating that when sleep improves
following hospital discharge, so too does cognitive functioning
(Dzierzewski et al., 2014), there is a dearth of research examining
the relationship between sleep and cognitive functioning in
hospitalized older adults. Such research is important, given the
increased risk for negative cognitive changes associated with
hospitalization in late-life (Wilson et al., 2012) and the relative
ease of assessing self-reported sleep duration.
The relationship between markers of inflammation and
cognitive performance is also not fully understood. Whereas,
some longitudinal studies have indicated a relationship between
high cytokine levels, for example, interleukin-6 (IL-6) and C-
reactive protein (CRP), and development of multiple forms of
dementia, data from the MacArthur Study of Successful Aging
indicated that there was only a limited association between
inflammatory factors and baseline cognitive function and the rate
of longitudinal cognitive decline after correcting for potential
confounders (Weaver et al., 2002; Teunissen et al., 2003; Baune
et al., 2008). Furthermore, in older adults, higher levels of
inflammatory markers have not been consistently associated
with poorer cognitive functioning (Teunissen et al., 2003). In
contrast to findings in healthy older adults, acute activation of
the inflammatory cascade in the context of recent changes in
health (e.g., infection, surgery) may be adaptive, serve to aid in
recovery from sickness, and have a different relationship with
cognitive functioning than chronic inflammation (Dantzer and
Kelley, 2007; Terrando et al., 2011). As such, additional research
is needed to determine the relationship between inflammation
and late-life cognitive functioning in hospitalized older adults.
The inconsistent relationships independently reported
between sleep and cognitive functioning and inflammation and
cognitive functioning may be partially explained by a general
lack of consideration for the relationships among sleep and
inflammation. Sleep duration appears to be directly related
to inflammation. Individuals with both irregularly short and
long sleep durations have been found to exhibit heightened
levels of inflammatory markers (Patel et al., 2009). As such, the
relationship between inflammation and cognitive functioning
may differ by sleep duration. As sleep in late-life is a relatively
malleable behavior (Dzierzewski et al., 2010), examination of
whether the relationship between inflammatory markers and
global cognitive functioning differs by sleep duration is of
theoretical and practical importance.
The current study aimed to examine the relationships
among sleep duration, inflammation, and global cognitive
function in older hospitalized men, accounting for the effects
of age, education, race, medical comorbidities/health, depressive
symptoms, pain, and body mass index (BMI). We hypothesized
that shorter sleep duration would be associated with worse global
cognitive functioning. In healthy, community-based samples
of older adults it would be expected that higher levels of
inflammatory markers [i.e., CRP, soluble intercellular adhesion
molecule (sICAM), tumor necrosis factor-alpha (TNFα), and IL-
6] would likely be related worse global cognitive functioning. In
the unique context of late-life hospitalization, we hypothesized
that there would be an association between levels of inflammatory
markers and global cognitive functioning, but it was not
clear in which direction this association might be expected to
occur. Lastly, we examined whether the association between
inflammation and global cognitive functioning differed by length
of sleep duration. Given the prior research which revealed
independent inconsistent associations between sleep duration
and cognitive functioning and between inflammation and
cognitive functioning, coupled with evidence that individuals
with varying durations of sleep exhibit different inflammatory
responses, we hypothesized that the relationship between
inflammation and global cognitive functioning would differ in
hospitalized older men with short sleep durations as compared
to those with more normal sleep durations.
Methods
Participants
Participants included in the present analysis were drawn from
two studies of sleep in older adults admitted for rehabilitation.
The first study was a descriptive study of sleep and inflammatory
markers (n = 36). The second study included the baseline
phase of an intervention trial to improve sleep during post-acute
rehabilitation (n = 151). Both studies were set in inpatient
rehabilitation units at a Veterans Affairs Medical Center, and
included 1 week of data collection. As such, they provide an
opportunity to examine predictors of cognitive functioning in
a unique sample of older adults who find themselves at an
increased risk for poor cognitive outcomes. Inclusion criteria
were identical for both studies, and included: (1) aged 60 years
or older; and (2) admitted for rehabilitation (i.e., receiving
physical or occupational therapy). Individuals were excluded if:
(1) found to have profound cognitive impairment [defined by
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Mini-Mental State Examination (MMSE)<12]; (2) had resided in
a nursing home prior to admission; (3) transferred, died, or were
discharged within 1 week of admission; (4) could not participate
in the study due to a severe medical illness or severe behavioral
disturbance; and (5) were unable to communicate verbally in
English during the screening process. Research methods were
reviewed and approved by the Veterans Administration Greater
Los Angeles Healthcare System Institutional Review Board (i.e.,
ethics committee), and informed consent was obtained from all
participants.
Procedures
Admission to the inpatient rehabilitation units at a Veterans
Affairs Medical Center was continuously monitored during
data collection to identify potential study participants. When
a potential research participant was identified (based upon
inclusion and exclusion criteria listed above), informed consent
was obtained and the patient was formally enrolled in the study.
After enrollment, all participants completed a comprehensive
assessment including collection of demographic, clinical, sleep,
and cognitive data, and measurement of inflammatory markers
(details below). First, individuals completed the MMSE to
establish eligibility and measure global cognitive functioning.
Eligible participants then completed a series of questionnaires
administered in interview format by a trained research assistant
at the patient’s bedside. On 1 day of monitoring, a blood sample
was collected by a study phlebotomist at 8 a.m. to measure
inflammatory markers.
Measures
Global Cognitive Functioning
We administered the MMSE, a 20-item measure of general
cognitive functioning; scores range from 0 to 30, with scores<24
suggestive of cognitive impairment (Folstein et al., 1975). MMSE
total score was used as a measure of general/global cognitive
functioning and to exclude those with profound cognitive
impairment as described above.
Demographic Data
Basic demographic information was recorded for all participants,
including age, education (measured in reported years of formal
education), and race (grouped as non-Hispanic white and all
others).
Clinical Data
Depressive symptoms were assessed with the 5-item version of
the Geriatric Depression Scale (score range = 0–5; scores >2
suggest clinically meaningful depression) (Rinaldi et al., 2003).
The experience of pain during the rehabilitation stay was
assessed with a modified version of the Geriatric Pain Measure
(GPM; higher scores indicate worse pain) (Ferrell et al., 2000).
Illness severity and comorbidity burden during acute inpatient
rehabilitation was computed with the Cumulative Illness Rating
Scale for Geriatrics (CIRS-G) (Miller et al., 1992; Parmelee et al.,
1995). This measure was completed by an experienced research
registered nurse, using data gathered during a brief physical
examination by a study physician and abstracted medical record
data. The CIRS-G quantifies comorbidity through rating of 14
body systems (e.g., heart, respiratory, liver) on a continuum from
no impairment to extremely severe impairment (Parmelee et al.,
1995). BMI was calculated frommeasures of height and weight in
patients’ medical records.
Sleep
Self-reported sleep duration over the prior 7 days was assessed
with the Pittsburgh Sleep Quality Index [PSQI; (Buysse et al.,
1989)]. The PSQI asks “How many hours of actual sleep
did you get at night?” Responses were categorized into the
following mutually exclusive groups, according to PSQI scoring
conventions (Buysse et al., 1989): (1) less than 5 h of sleep per
night, (2) 5–6 h of sleep per night, (3) 6–7 h of sleep per night, and
(4) more than 7 h of sleep per night. As such, the PSQI provides
an index of sleep duration ranging from short sleep length to
average sleep length.
Inflammatory Markers
One blood sample was collected per participant into an
anticoagulated (EDTA) tube at 8 a.m. on one morning of
the study. Samples were centrifuged at 4◦C, and aliquots of
plasma were prepared for storage within 30min of collection,
and then immediately frozen at −70◦C until assays were
conducted. At the end of the studies, plasma samples were
thawed and assayed for inflammatory markers. Each sample
was assayed in duplicate using enzyme-linked immunosorbent
assays (ELISAs), according to manufacturer’s instructions except
as noted. CRP levels were determined by a high sensitivity ELISA
(Immundiagnostik, ALPCO Immunoassays, Salem, NH) at a
routine sample dilution of either 1:200 or 1:500 (up to 1:2000
as needed), and with an extended standard curve, for an assay
range of 0.2–300 mg/L (taking the sample dilution into account).
Plasma levels of TNFα and IL-6 were determined by Quantikine
High Sensitivity ELISAs (R&D Systems, Minneapolis, MN); IL-
6 samples were routinely diluted 3-fold, and when necessary,
further diluted up to 20-fold in order to measure samples with
IL-6 concentrations up to 200 pg/mL (taking sample dilution
into account). Measurement of sICAM-1 was performed using a
regular sensitivity sICAM-1 ELISA (R&D Systems, Minneapolis,
MN). For all four inflammatory markers, intra-assay variability
was less than 6% and inter-assay variability was less than 8%.
Statistical Analyses
Data were analyzed with IBM SPSS 22 statistical software.
Independent sample t-tests were used to compare characteristics
of those with complete data (i.e., the included sample) and those
with one or more missing data points (i.e., the excluded sample).
Four separate, 3-block hierarchical regressions were estimated
to predict general/global cognitive functioning (i.e., MMSE total
score). In Block 1, demographic (i.e., age, education, race) and
clinical information (i.e., comorbidity/health, depression, pain,
and BMI) were entered. In Block 2, sleep duration and a single
inflammatory marker, either CRP (mg/L), sICAM-1 (ng/mL),
IL-6 (pg/mL), or TNFα (pg/mL), were entered. In Block 3, the
interaction term between sleep duration and the inflammatory
marker (either CRP, sICAM-1, IL-6, or TNFα) was entered. The
four separate hierarchical regression models only differed by the
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specific inflammatory marker included in the model. Models
were evaluated based on indicators of model fit, while individual
predictors were evaluated based on significance levels. Follow-
up analysis involved examination of simple slopes and regions
of significance (Preacher et al., 2006). To reduce the influence of
extreme values, the highest 5% of inflammatory marker values
(equivalent to 2 SDs) were replaced with the values at the
95th percentile (Field, 2005). All variables were transformed
using the Blom transformation (Blom, 1958) prior to statistical
analysis. For all analyses, p < 0.05 was considered statistically
significant.
Results
Sample Characteristics
In total, 187 older men were deemed eligible and provided at
least some data. Of these, 135 (mean age 72.9 ± 9.7 years)
provided complete data and were included in the present
analysis. On average, these older men had above high school
levels of education (mean education 13.9 ± 3 years), were
predominantly non-Hispanic white (62%), had low levels of
depressive symptoms (GDS-5 mean 1.5 ± 1.4), moderate levels
of pain (mean GPM 50 ± 27.8), experienced moderate levels
of physical comorbidities (mean CIRS-G 22 ± 5.4), and were
overweight (mean BMI 27.0 ± 5.5). Median levels (and 25th–
75th percentile ranges) of inflammatory markers were: CRP 19.0
(4.4–59.1) mg/L, sICAM-1 263 (221–337) ng/mL, IL-6 9.4 (5.3–
16.6) pg/mL, and 1.9 (1.5–2.4) TNFα pg/mL. Distribution of
sleep duration was as follows: 28% reported sleeping for more
than 7 h per night, 20% reported sleeping between 6 and 7 h
per night, 20% reported sleeping between 5 and 6 h per night,
and 32% reported sleeping less than 5 h per night. As expected
after excluding those with profound cognitive impairment, the
sample was generally cognitively healthy (mean MMSE 25.8 ±
3.4). The only significant difference between individuals with
incomplete data (n = 52) and complete data (n = 135) was
that participants with incomplete data were older than those who
provided complete data (p = 0.012, mean age = 76.5 years
vs. 72.9 years, respectively). See Table 1 for complete listings of
demographic and clinical data.
Hierarchical Regressions Predicting Global
Cognitive Functioning
Final model statistics are presented in Table 2. Age and racial
group emerged as consistent predictors of MMSE scores across
the different inflammatory marker regression models, suggesting
that younger men within this study population, and non-
Hispanic whites among all men, had higher (i.e., better) MMSE
scores. Sleep duration was not a direct significant predictor
of MMSE scores. Only sICAM was a significant independent
predictor of MMSE scores, β = 0.21, p < 0.01, suggesting
men with higher levels of sICAM during hospitalization had
higher MMSE scores. The interactions between sleep duration
and CRP, β = −0.19, p < 0.05, and sleep duration and
sICAM, β = −0.18, p < 0 05 were significant, suggesting that
the relationship between inflammation and global cognitive
functioning differed by sleep duration groups. The CRP and
sICAM models explained significant variance in global cognitive
functioning, final model adjusted R2 of 21 and 22%, respectively.
Likewise, the addition of the interaction term between sleep
duration and the inflammatory marker resulted in significant
improvement in model fit for both the CRP and sICAM
models.
To further explicate the moderating effect in the relationship
between inflammation and general cognitive functioning by
sleep duration, we graphed the inflammation-global cognitive
functioning relationship for older men separately by sleep
duration groups (Figure 1; CRP model on the left, sICAMmodel
on the right). As is illustrated, for CRP and sICAM, short
sleep duration attenuates the relationship between inflammation
and global cognitive functioning. Simple slope analysis revealed
that men with short sleep durations (i.e., less than 5 h per
night) do not demonstrate a significant relationship between
inflammation and global cognitive functioning [t(130) = −0.84,
p > 0.05; t(130) = 0.03, p > 0.05, respectively for CRP and
sICAM]. However, older men with sleep durations greater than
6 h per night show significant positive relationships between
inflammation and global cognitive functioning. The highest
levels of global cognitive functioning was seen among older men
with higher levels of inflammatory markers who slept more than
7 h per night [t(130) = 2.82, p < 0.01; t(130) = 3.13, p < 0.01,
respectively CRP and sICAM]. The region of significance analysis
indicated that differences in global cognitive functioning between
sleep duration groups occurred below Blom-transformed values
of CRP = −0.025 and sICAM = 0.024 (equivalent to 38.9mg/L
and 272 ng/mL, respectively).
Discussion
The current study examined the relationships among sleep
duration, inflammatory factors, and global cognitive functioning
in a sample of older men who are at an increased risk
for cognitive difficulties, those who were recovering from
acute health changes in an inpatient setting. Our hypothesis
that shorter sleep duration would be associated with worse
global cognitive functioning was not supported. Similarly, our
hypothesis that levels of inflammatory markers would be related
to global cognitive functioning was only supported in the sICAM
model, and not in models examining CRP, TNFα, or IL6.
Our last hypothesis regarding moderation of the inflammation-
global cognitive functioning relationship by sleep duration was
partially supported. We found that hospitalized older men with
short sleep durations do not show any significant relationship
between inflammation and global cognitive functioning, while
hospitalized older men with sleep durations greater than
6 h per night show significant positive relationships between
inflammation and global cognitive functioning.
In community-dwelling older adults, sleep duration has
shown inconsistent relationships with cognitive functioning. Our
finding in hospitalized older men aligns with investigators who
have reported no significant association between sleep duration
and cognitive functioning (Nebes et al., 2009). Interestingly, there
have been reported negative relationships between abnormally
long sleep duration (≥11 h) and general cognitive functioning
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TABLE 1 | Patient demographics and descriptive variables.
Included sample (n = 135) Excluded sample (n = 52) t/χ2 df P
Mean (SD) Mean (SD)
Age (years) 72.9 (9.7) 76.5 (8.8) 2.56 109.1a 0.01
Education (years) 13.9 (3.0) 13.1 (2.6) −1.21 156 > 0.05
Race (% White) 62.2% 61.5% 0.01 1 > 0.05
GDS Score 1.5 (1.4) 1.4 (1.4) −0.29 182 > 0.05
GPM Score 50.0 (27.8) 46.1 (29.5) −0.78 175 > 0.05
CIRS Total Score 22.0 (5.4) 23.4 (5.6) 1.44 175 > 0.05
BMI 27.0 (5.5) 28.2 (10.5) 0.74 50.88a > 0.05
Sleep Duration (% of respondents) 0.37 179 > 0.05
Less than 5 h 32.9% 32.6%
5 to 6 h 20.0% 21.7%
6 to 7 h 20.0% 21.7%
Greater than 7 h 28.1% 23.9%
CRP [median (25%ile, 75%ile)] 19.0 (4.4, 59.1) 19.9 (5.8, 65.4) 0.22 183 > 0.05
sICAM [median (25%ile, 75%ile)] 263 (221, 337) 247 (197, 330) −1.39 183 > 0.05
TNFα [median (25%ile, 75%ile)] 1.9 (1.5, 2.4) 1.9 (1.4, 2.6) −0.46 183 > 0.05
IL6 [median (25%ile, 75%ile)] 9.4 (5.3, 16.6) 10.7 (5.4, 20.5) 0.53 185 > 0.05
MMSE Score 25.8 (3.4) 24.5 (4.3) −1.93 76.62a > 0.05
Race dichotomously coded as non-Hispanic white = 1, all other = 0; GDS, Geriatric Depression Scale, modified 5-item version; GPM, Geriatric Pain Measure; CIRS, Cumulative
Illness Rating Scale; BMI, body mass index; CRP, C-reactive protein (mg/L); sICAM, soluble Intercellular Adhesion Molecule (ng/mL); TNFα, Tumor Necrosis Factor-alpha (pg/mL); IL6,
Interleukin-6 (pg/mL).
adegrees of freedom and t-statistic were adjusted for non-homogeneity of variance.
in older samples (Faubel et al., 2009). Perhaps it is abnormally
long sleep durations that are associated with deleterious cognitive
changes in hospitalized older men. Our categorization of sleep
duration was limited by the scoring protocol of the PSQI. As
such, we were not able to examine long sleepers as a separate
group, as any abnormally long sleepers would have been lumped
into the greater than 7 h per night of sleep group. Future
research should continue to explore these relationships. Another
potential explanation for the lack of associations between sleep
duration and global cognitive functioning may be the underlying
poor health status of our sample. Physical health is a robust
predictor of late-life cognitive functioning (Zelinski et al., 1998),
and late-life sleep disturbances are largely related to health
status (Grandner et al., 2012). Our sample may have been
too homogenous regarding health status as we controlled for
depression, pain, comorbidity severity/burden, and BMI in a
sample of older men all recovering from an acute health
event.
An innovation of our study was the examination of markers
of inflammation and cognitive functioning in the context of
sleep duration. Increased levels of inflammatory markers are
associated with a number of negative health outcomes in older
people. Previous studies have observed negative relationships
between inflammatory markers and cognitive functioning in
late-life (Gunstad et al., 2006; Baune et al., 2008), although
these studies primarily focused on healthy older adults without
consideration of sleep. Interestingly, it has been suggested that
a potential route through which higher circulating levels of
cytokines and their downstream products may negatively impact
cognitive functioning is through “impaired sleep regulation”
(Wilson et al., 2002). Elevations of inflammatory markers in
response to acute health events is a normal innate immune
response (Heinrich et al., 1990; Dantzer and Kelley, 2007).
Perhaps individuals who had sufficient immune system capacity
to respond to physiological insult with elevated inflammatory
levels were also healthier patients, or at least, had greater
physical and mental reserves upon which to draw. Adequate
sleep duration may facilitate immune functioning and recovery.
Such an interpretation is consistent with the moderation results
which indicated that older men who slept more than 6 h per night
demonstrated a positive relationship between inflammatory
markers and global cognitive functioning. In the case of CRP,
an acute phase protein produced by the liver, this might reflect
better hepatic function. For sICAM-1, which is essential to
the migration of leukocytes to sites of inflammation, elevated
levels during acute health challenges might reflect appropriate
recruitment and migration of leukocytes via vascular endothelial
cells. Short sleep durations may dampen these processes,
while normal sleep durations may promote or enable these
processes.
The present study has several limitations. Our findings pertain
to hospitalized older men. While hospitalized older men are at
increased risk for future decline (Martin et al., 2011;Wilson et al.,
2012), and as such represent an important group to be studied,
results may not generalize to non-hospitalized older adults
or to older women. Also, cognitive functioning was assessed
with a single global indicator (MMSE). Future studies should
collect multiple indicators of sleep duration (e.g., self-reported
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TABLE 2 | Summary of hierarchical regression analysis predicting general cognitive functioning (n = 135).
CRP sICAM TNFα IL6
B (SE) β B (SE) β B (SE) β B (SE) β
BLOCK 1
Age (years) −0.29 (0.08) −0.32*** −0.29 (0.08) −0.32*** −0.29 (0.08) −0.32*** −0.29 (0.08) −0.32***
Education (years) 0.13 (0.08) 0.14 0.14 (0.08) 0.14 0.13 (0.08) 0.14 0.13 (0.08) 0.14
Race 0.26 (0.11) 0.19* 0.25 (0.11) 0.18* 0.26 (0.11) 0.19* 0.26 (0.11) 0.19*
GDS Score −0.12 (0.09) −0.11 −0.12 (0.09) −0.11 −0.12 (0.09) −0.11 −0.12 (0.09) −0.11
GPM Score −0.02 (0.08) −0.02 −0.01 (0.08) −0.01 −0.02 (0.08) −0.02 −0.01 (0.08) −0.01
CIRS Total Score −0.12 (0.08) −0.13 −0.13 (0.08) −0.14 −0.12 (0.08) −0.13 −0.13 (0.08) −0.13
BMI −0.02 (0.08) −0.02 −0.02 (0.08) −0.02 −0.02 (0.08) −0.02 −0.02 (0.08) −0.02
Adjusted R2 0.18 0.18 0.18 0.18
F for Change in R2 5.05*** 5.08*** 5.05*** 5.06***
BLOCK 2
Age (years) −0.26 (0.09) −0.28** −0.27 (0.08) −0.30*** −0.29 (0.08) −0.32*** −0.29 (0.08) −0.32***
Education (years) 0.14 (0.08) 0.15 0.12 (0.08) 0.13 0.13 (0.08) 0.14 0.14 (0.08) 0.15
Race 0.23 (0.11) 0.17* 0.20 (0.11) 0.14 0.26 (0.11) 0.19* 0.24 (0.11) 0.17*
GDS Score −0.10 (0.09) −0.09 −0.13 (0.09) −0.13 −0.12 (0.09) −0.12 −0.12 (.09) −0.11
GPM Score −0.02 (0.08) −0.02 −0.01 (0.08) −0.01 −0.01 (0.08) −0.01 −0.01 (0.08) −0.02
CIRS Total score −0.14 (0.08) −0.15 −0.15 (0.08) −0.16 −0.12 (0.08) −0.13 −0.14 (0.08) −0.15
BMI −0.02 (0.08) −0.02 −0.03 (0.08) −0.03 −0.02 (0.08) −0.02 −0.02 (0.08) −0.02
Sleep duration 0.0003 (0.09) 0.0003 −0.03 (0.09) −0.03 −0.01 (0.09) −0.005 −0.002 (0.09) −0.002
Inflammatory marker† 0.12 (0.08) 0.13 0.18 (0.08) 0.19* 0.01 (0.08) 0.01 0.07 (0.07) 0.08
Adjusted R2 0.18 0.20 0.16 0.17
F for change in R2 1.20 2.77 0.01 0.45
BLOCK 3
Age (years) −0.22 (0.09) −0.24* −0.27 (0.08) −0.29*** −0.29 (0.08) −0.32*** −0.28 (0.08) −0.30***
Education (years) 0.12 (0.08) 0.13 0.12 (0.07) 0.13 0.14 (0.08) 0.15 0.14 (0.08) 0.14
Race 0.22 (0.11) 0.16* 0.21 (0.11) 0.16 0.26 (0.11) 0.19* 0.24 (0.11) 0.17*
GDS Score −0.11 (0.09) −0.11 −0.16 (0.09) −0.16 −0.12 (0.09) −0.12 −0.13 (0.09) −0.12
GPM Score −0.005 (0.08) −0.005 −0.003 (0.08) −0.003 −0.01 (0.08) −0.01 −0.01 (0.08) −0.02
CIRS Total Score −0.17 (0.08) −0.19* −0.14 (0.08) −0.15 −0.12 (0.08) −0.13 −0.15 (0.08) −0.16
BMI −0.03 (0.08) −0.03 −0.06 (0.08) −0.06 −0.02 (0.08) −0.02 −0.03 (0.08) −0.03
Sleep Duration 0.01 (0.09) 0.01 −0.03 (0.09) −0.02 −0.01 (0.09) −0.005 −0.01 (0.09) −0.01
Inflammatory Marker† 0.10 (0.08) 0.11 0.20 (0.08) 0.21** 0.01 (0.08) 0.01 0.06 (0.08) 0.06
SleepX Inflammation −0.21 (0.09) −0.19* −0.20 (0.09) −0.18* −0.06 (0.10) −0.05 −0.11 (0.09) −0.09
Adjusted R2 0.21 0.22 0.16 0.17
F for Change in R2 5.30* 5.00* 0.35 1.28
Race dichotomously coded as non-Hispanic white = 1, all other = 0; GDS, Geriatric Depression Scale, modified 5-item version; GPM, Geriatric Pain Measure; CIRS, Cumulative Illness
Rating Scale; BMI, body mass index; CRP, C-reactive protein; sICAM, soluble Intercellular Adhesion Molecule; TNFα, Tumor Necrosis Factor-alpha; IL6, Interleukin-6. †CRP, sICAM,
TNFα, or IL6. *p < 0.05; **p < 0.01; ***p < 0.001.
prospective and retrospective, actigraphy, polysomnography),
along with examination of the relationship among various
domains of cognition, such as executive functioning, attention,
and working memory. In our sample, both CRP and IL-6
levels were generally high and well above reported national
averages for non-hospitalized individuals (Ford, 1999). As the
current sample was drawn from an inpatient rehabilitation
unit, we expected elevations in inflammatory markers. To be
conservative, we trimmed extreme outliers at the highest 5% of
values and normalized the data through Blom transformations
(Blom, 1958). Additionally, it was not possible to exclude
individuals with inflammatory diseases on admission or to
ascertain whether we completed blood draws while patients
were in the acute phase response of their illness, which is
considered a normal response to bodily insult and include
significant increases in both IL-6 and CRP (Heinrich et al.,
1990). In fact, the region of significance analysis (see Figure 1)
suggested that differences in global cognitive functioning
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FIGURE 1 | Interaction between CRP (left panel, mg/L) and sICAM
(right panel, ng/mL) and sleep duration. CRP, sICAM, and MMSE
variables were transformed using the Blom transformation prior to
analyses. All variables were transformed back to their original metric prior
to graphing. Values to the left of the vertical bold lines fall within the
regions of significance.
between sleep duration groups occurred in the lower half of the
range of the inflammation distributions. Future investigations
might employ more sophisticated analytical techniques which
could more clearly parse out the unique contributions of
sleep and inflammation on late-life cognitive functioning.
Lastly, there are many medications with known inflammatory
consequences, and these were not accounted for in the present
analysis.
We discovered that the relationship between inflammatory
markers and global cognitive functioning was dependent
on sleep duration in a group of older men hospitalized for
rehabilitation services. These relationships were observed after
controlling for age, education, race, comorbidity severity/burden,
depression, pain, and BMI. Future studies of cognitive
functioning in hospitalized older adults would be wise to include
measures of self-reported sleep duration and determinations
of circulating levels of CRP and sICAM. Additionally, as
sleep remains malleable well into late-life (Dzierzewski et al.,
2010), future work should explore sleep interventions as
a means promote recovery and/or delay cognitive decline
following hospitalizations. Lastly, the results of the present
study highlight the importance of context when investigating
predictors, especially inflammation, of late-life cognitive
functioning.
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